Staphylococcus aureus infections: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Changes made per Mahshid's request |
||
(3 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
Select a topic from the list below: | Select a topic from the list below: | ||
[[Methicillin-resistant Staphylococcus aureus]] | [[Methicillin-resistant Staphylococcus aureus]] | ||
Line 38: | Line 40: | ||
[[VISA / VRSA: Vancomycin-Intermediate/Resistant Staphylococcus aureus]] | [[VISA / VRSA: Vancomycin-Intermediate/Resistant Staphylococcus aureus]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] |
Latest revision as of 18:51, 18 September 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Select a topic from the list below:
Methicillin-resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus (MRSA)
Vancomycin-resistant Staphylococcus aureus
VISA / VRSA: Vancomycin-Intermediate/Resistant Staphylococcus aureus